Antiporphyric effect exerted by caffeine administration in allylisopropylacetamide-treated rats.
D000624:5-Aminolevulinate Synthetase / Q000037:antagonists & inhibitors*; D000081:Acetamides / Q000494:pharmacology*; D000502:Allylisopropylacetamide / Q000494:pharmacology*; D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D006418:Heme / Q000494:pharmacology; D008099:Liver / Q000187:drug effects; D008862:Microsomes, Liver / Q000032:analysis / Q000201:enzymology; D009929:Organ Size; D011166:Porphyrins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D011506:Proteins / Q000032:analysis; D051381:Rats
D000081:Acetamides; D011166:Porphyrins; D011506:Proteins; D000502:Allylisopropylacetamide; D002110:Caffeine; D006418:Heme; D003577:Cytochrome P-450 Enzyme System; D000624:5-Aminolevulinate Synthetase